BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16175929)

  • 21. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
    J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial Dysfunction in the Liver and Antiphospholipid Antibody Production Precede Disease Onset and Respond to Rapamycin in Lupus-Prone Mice.
    Oaks Z; Winans T; Caza T; Fernandez D; Liu Y; Landas SK; Banki K; Perl A
    Arthritis Rheumatol; 2016 Nov; 68(11):2728-2739. PubMed ID: 27332042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice.
    Hasegawa H; Kohno M; Sasaki M; Inoue A; Ito MR; Terada M; Hieshima K; Maruyama H; Miyazaki J; Yoshie O; Nose M; Fujita S
    Arthritis Rheum; 2003 Sep; 48(9):2555-66. PubMed ID: 13130475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ethyl acetate extract of alfalfa sprout ameliorates disease severity of autoimmune-prone MRL-lpr/lpr mice.
    Hong YH; Huang CJ; Wang SC; Lin BF
    Lupus; 2009 Mar; 18(3):206-15. PubMed ID: 19213858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monocyte chemoattractant protein-1 activates a regional Th1 immunoresponse in nephritis of MRL/lpr mice.
    Shimizu S; Nakashima H; Karube K; Ohshima K; Egashira K
    Clin Exp Rheumatol; 2005; 23(2):239-42. PubMed ID: 15895897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy.
    Yang CW; Ahn HJ; Kim WY; Li C; Jung JY; Yoon SA; Kim YS; Cha JH; Kim J; Bang BK
    Transplantation; 2003 Feb; 75(3):309-15. PubMed ID: 12589150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis.
    Devarapu SK; Kumar Vr S; Rupanagudi KV; Kulkarni OP; Eulberg D; Klussmann S; Anders HJ
    Clin Immunol; 2016 Aug; 169():139-147. PubMed ID: 27392463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway.
    Gu Z; Tan W; Ji J; Feng G; Meng Y; Da Z; Guo G; Xia Y; Zhu X; Shi G; Cheng C
    Aging (Albany NY); 2016 May; 8(5):1102-14. PubMed ID: 27048648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human embryonic mesenchymal stem cells alleviate pathologic changes of MRL/Lpr mice by regulating Th7 cell differentiation.
    Yuan L; Xiao ZT; Huang XZ; Wu MJ; Shi H; Liu AF
    Ren Fail; 2016 Oct; 38(9):1432-1440. PubMed ID: 27416851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant expression pattern of histone acetylation modifiers and mitigation of lupus by SIRT1-siRNA in MRL/lpr mice.
    Hu N; Long H; Zhao M; Yin H; Lu Q
    Scand J Rheumatol; 2009; 38(6):464-71. PubMed ID: 19922023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclosporine withdrawal and mycophenolate mofetil treatment effects on the progression of chronic cyclosporine nephrotoxicity.
    Yang CW; Ahn HJ; Kim WY; Li C; Kim HW; Choi BS; Cha JH; Kim YS; Kim J; Bang BK
    Kidney Int; 2002 Jul; 62(1):20-30. PubMed ID: 12081560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1 beta, interleukin-1 and interferon-gamma mRNA in the lymph nodes of lupus-prone mice.
    Prud'homme GJ; Kono DH; Theofilopoulos AN
    Mol Immunol; 1995 May; 32(7):495-503. PubMed ID: 7783752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus.
    Boswell JM; Yui MA; Endres S; Burt DW; Kelley VE
    J Immunol; 1988 Jul; 141(1):118-24. PubMed ID: 3259964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritis.
    Zoja C; Benigni A; Noris M; Corna D; Casiraghi F; Pagnoncelli M; Rottoli D; Abbate M; Remuzzi G
    Kidney Int; 2001 Aug; 60(2):653-63. PubMed ID: 11473648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice.
    Takahashi S; Fossati L; Iwamoto M; Merino R; Motta R; Kobayakawa T; Izui S
    J Clin Invest; 1996 Apr; 97(7):1597-604. PubMed ID: 8601623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebellar dysfunction is associated with overexpression of proinflammatory cytokine genes in lupus.
    Tomita M; Holman BJ; Williams LS; Pang KC; Santoro TJ
    J Neurosci Res; 2001 Apr; 64(1):26-33. PubMed ID: 11276048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of nonmyeloablative unrelated fetal and neonatal murine peripheral blood mononuclear cell infusion on MRL/lpr mice.
    Chuan W; Wu-qing W; Zhu-wen Y; Zuo L
    Lupus; 2014 Sep; 23(10):994-1005. PubMed ID: 24756437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antagonizing miR-7 suppresses B cell hyperresponsiveness and inhibits lupus development.
    Wang M; Chen H; Qiu J; Yang HX; Zhang CY; Fei YY; Zhao LD; Zhou JX; Wang L; Wu QJ; Zhou YZ; Zhang W; Zhang FC; Zhang X; Lipsky PE
    J Autoimmun; 2020 May; 109():102440. PubMed ID: 32201226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-1 beta gene expression in B cells derived from the murine MRL/lpr model of lupus.
    Mao C; Singh AK
    Autoimmunity; 1996; 24(2):71-9. PubMed ID: 8986320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycophenolate mofetil inhibits macrophage infiltration and kidney fibrosis in long-term ischemia-reperfusion injury.
    Jiang S; Tang Q; Rong R; Tang L; Xu M; Lu J; Jia Y; Ooi Y; Hou J; Guo J; Yang B; Zhu T
    Eur J Pharmacol; 2012 Aug; 688(1-3):56-61. PubMed ID: 22609232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.